2X7

OrthoPediatrics Corp

Healthcare · EUR · F

2X7

Price

€15.192

-1.48%

Cap

€457.45M

Earnings

30d Trend

+12.4%

2X7
Loading chart data...
0 days · % change from startPowered by Brain47
VolatilityHigh

43% annualised over 90 days

BRAIN47 SIGNAL

0
WEAK
Risk Level70
Quality59
Momentum9
Technical59
Fundamentals75

Raw weighted: 39×Macro 0.99 (1%)=39

RISK

70/100
90d Volatility
42.7%High
ATR %
4.3%High daily moves
Max Drawdown (1Y)
-38.2%Volatile

QUALITY

59/100
ROE (avg)
-11.4%Negative
Piotroski F-Score
5/9Average
Debt/Equity
0.31Low leverage
Margin Stability
CV 1.7%Very stable
Accruals
-6.8%Cash earnings

MOMENTUM

9/100
12-1M Momentum
-34.2%Strong downtrend
6-1M Momentum
-25.3%Negative
1M Return
+21.7%Strong recent gains

TECHNICAL

59/100
RSI (14)
55.1Neutral
Price vs SMA200
+0.2%Flat
MACD
-0.01Bearish momentum
Bollinger Band
59%Mid-range
SMA Cross
Golden CrossGolden Cross
Trend Quality (KER)
0.474Mixed

FUNDAMENTALS

75/100
P/S
1.8Cheap

Macro: neutral (×0.99) - Fear/Greed: 64 (Greed) - Data: 100%

Running historical backtest...

BRAIN47 HORIZON ANALYSIS

<3 months54
3-12 months38
1-5+ years53

Limited short-term thesis

BRAIN47'S ASSESSMENT

I rate OrthoPediatrics Corp at 39/100 — a WEAK reading on the Brain47 Signal. The strongest factor is fundamentals at 75/100. I classify this as a speculative position with the strongest thesis on a short-term horizon.

PAST PERFORMANCE

1 MONTH

+21.7%

3 MONTHS

-7.1%

12 MONTHS

-12.5%

Trailing returns — past performance, not a projection.

DETAILED ANALYSIS

Limited short-term thesis. Fundamentals (75) and Quality (59) are the primary strengths. I note that momentum is the weakest area at 9/100 — this warrants monitoring. Historical volatility is elevated at 43%. I classify this as a speculative position — elevated volatility at 43% and smaller market cap define the opportunity.

speculativeScore: 39/100

Want full analysis on every stock?

Brain47 provides AI-powered research across 72,000+ instruments. Stocks, ETFs, REITs and more.

Join Brain47 — Free

Generated by Brain47 AI. Educational research only. Not financial advice. Brain47 is not authorised by the FCA to provide investment advice.